HLA-DQA1
HLA-DQA1 (major histocompatibility complex, class II, DQ alpha 1) encodes the alpha chain of the HLA-DQ class II molecule, which binds peptides from endocytosed antigens and presents them to CD4 T-cells. It is also known as CELIAC1 or HLA-DQA. Browse Assay Genie's current range of HLA-DQA1 research reagents below, or read on for the biology behind the target.
HLA-DQA1 is the alpha chain of the DQ class II molecule, a heterodimer in which it pairs with a DQ beta chain (DQB), both anchored in the membrane. The molecule binds peptides derived from antigens that enter the endocytic route of antigen presenting cells and displays them at the cell surface for recognition by CD4 T-cells. Its peptide-binding cleft accommodates peptides of 10-30 residues. These peptides arise mostly from proteins degraded by lysosomal proteases and other hydrolases, so exogenous antigens must compete with endogenous membrane proteins and with peptides supplied by autophagy.
Assembly begins in the endoplasmic reticulum, where three alpha-beta heterodimers associate with a CD74 trimer to form a heterononamer. After the complex enters the endosomal/lysosomal system, proteases including CTSS and CTSL degrade CD74 and leave the CLIP fragment. HLA-DM binds the alpha-beta-CLIP complex, releases CLIP and stabilises the molecule until a high-affinity peptide is bound. In B-cells, HLA-DO regulates this interaction. The peptide-loaded molecule then travels to the cell surface. Lysosomal acidification promotes proteolysis and efficient peptide loading.
The HLA-DQA1 gene belongs to the HLA class II alpha chain paralogues and is part of the histocompatibility complex and C1-set domain gene groups. Class II molecules are expressed in B lymphocytes, dendritic cells and macrophages, and gastrointestinal epithelial cells can also act as antigen presenting cells. The gene has five exons: exon 1 encodes the leader peptide, exons 2 and 3 the two extracellular domains, and exon 4 the transmembrane domain and cytoplasmic tail. Both the alpha and beta chains carry polymorphisms that specify peptide-binding preferences, giving up to four different DQ molecules. Typing for these polymorphisms is routine for bone marrow transplantation.
HLA-DQA1 forms part of the MHC class II molecule that presents endocytosed peptides to CD4 T-cells.
Its loading involves CD74, CLIP removal by HLA-DM and lysosomal proteolysis, making it relevant to exogenous presentation studies.
Polymorphisms in the DQ alpha and beta chains are typed routinely for bone marrow transplantation.
Gastrointestinal epithelial cells express MHC class II and act as antigen presenting cells, an unusual trait of the gut.
HLA-DQA1 encodes the alpha chain of the HLA-DQ class II molecule. Paired with a DQ beta chain, it binds peptides from antigens in the endocytic route and presents them at the cell surface to CD4 T-cells, playing a central role in the immune system.
Aliases include CELIAC1 and HLA-DQA. The UniProt protein name is HLA class II histocompatibility antigen, DQ alpha 1 chain. HGNC lists the gene as major histocompatibility complex, class II, DQ alpha 1, within the histocompatibility complex gene group.
Both the DQ alpha and beta chains carry polymorphisms that determine peptide-binding specificity, giving up to four different DQ molecules. Typing for these polymorphisms is routinely done for bone marrow transplantation. Check the datasheet of any product for its validated reactivity.
Other HLA class II chains, classical and non-classical HLA class I molecules and related antigen presentation targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P01909; product specifications from Assay Genie datasheets.